Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Kulke MH; Bergsland EK; Ryan DP; Enzinger PC; Lynch TJ; Zhu AX; Meyerhardt JA; Heymach JV; Fogler WE; Sidor C; Michelini A; Kinsella K; Venook AP; Fuchs CS; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2006, vol. 24, issue 22, p 3555, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef